Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.07.021
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Elsevier BV